These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17156290)

  • 1. A semiparametric empirical likelihood method for biased sampling schemes with auxiliary covariates.
    Wang X; Zhou H
    Biometrics; 2006 Dec; 62(4):1149-60. PubMed ID: 17156290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A semiparametric empirical likelihood method for data from an outcome-dependent sampling scheme with a continuous outcome.
    Zhou H; Weaver MA; Qin J; Longnecker MP; Wang MC
    Biometrics; 2002 Jun; 58(2):413-21. PubMed ID: 12071415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
    Kancha RK; von Bubnoff N; Peschel C; Duyster J
    Clin Cancer Res; 2009 Jan; 15(2):460-7. PubMed ID: 19147750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.
    Fukui T; Ohe Y; Tsuta K; Furuta K; Sakamoto H; Takano T; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Asamura H; Tsuchida T; Kaneko M; Kusumoto M; Yamamoto S; Yoshida T; Tamura T
    Clin Cancer Res; 2008 Aug; 14(15):4751-7. PubMed ID: 18676744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of EGFR mutation analysis in non-small cell lung cancer.
    Yamamoto H; Toyooka S; Mitsudomi T
    Lung Cancer; 2009 Mar; 63(3):315-21. PubMed ID: 18760859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiparametric estimation in generalized linear mixed models with auxiliary covariates: a pairwise likelihood approach.
    Liu L; Xiang L
    Biometrics; 2014 Dec; 70(4):910-9. PubMed ID: 25251282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process.
    Hoshi K; Takakura H; Mitani Y; Tatsumi K; Momiyama N; Ichikawa Y; Togo S; Miyagi T; Kawai Y; Kogo Y; Kikuchi T; Kato C; Arakawa T; Uno S; Cizdziel PE; Lezhava A; Ogawa N; Hayashizaki Y; Shimada H
    Clin Cancer Res; 2007 Sep; 13(17):4974-83. PubMed ID: 17785547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on epidermal growth factor receptor mutations in non-small cell lung cancer.
    Riely GJ; Politi KA; Miller VA; Pao W
    Clin Cancer Res; 2006 Dec; 12(24):7232-41. PubMed ID: 17189394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust variance estimation for the case-cohort design.
    Barlow WE
    Biometrics; 1994 Dec; 50(4):1064-72. PubMed ID: 7786988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR assays in lung cancer.
    Dacic S
    Adv Anat Pathol; 2008 Jul; 15(4):241-7. PubMed ID: 18580100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small sample inference for fixed effects from restricted maximum likelihood.
    Kenward MG; Roger JH
    Biometrics; 1997 Sep; 53(3):983-97. PubMed ID: 9333350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
    Ohtsuka K; Ohnishi H; Fujiwara M; Kishino T; Matsushima S; Furuyashiki G; Takei H; Koshiishi Y; Goya T; Watanabe T
    Cancer; 2007 Feb; 109(4):741-50. PubMed ID: 17238183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
    Yung TK; Chan KC; Mok TS; Tong J; To KF; Lo YM
    Clin Cancer Res; 2009 Mar; 15(6):2076-84. PubMed ID: 19276259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor (EGFR) double-activating somatic mutations in exons 19 and 21 in Japanese non-small cell lung cancer patients.
    Masago K; Fujita S; Kim YH; Ichikawa M; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Mio T; Mishima M
    Cancer Genet Cytogenet; 2009 Dec; 195(2):179-82. PubMed ID: 19963121
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-stage method of estimation for general linear growth curve models.
    Stukel TA; Demidenko E
    Biometrics; 1997 Jun; 53(2):720-8. PubMed ID: 9192460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC; Chow AS; Au JS
    Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood methods for regression models with expensive variables missing by design.
    Zhao Y; Lawless JF; McLeish DL
    Biom J; 2009 Feb; 51(1):123-36. PubMed ID: 19197954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling continuous auxiliary covariate data in generalized linear mixed models using the kernel smoother.
    Chen J; Lin CD
    Biom J; 2010 Jun; 52(3):362-76. PubMed ID: 20518048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiparametric analysis of two-level bivariate binary data.
    Naskar M; Das K
    Biometrics; 2006 Dec; 62(4):1004-13. PubMed ID: 17156274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.